Latest news

Insights

Reinventing the Pharmaceutical Commercial Model

Executive Summary The pharmaceutical commercial model is entering a period of structural change. For decades, commercial organizations have relied on relatively...
Commercial

Eli Lilly Files Six Lawsuits Over Sales of Unapproved Retatrutide

Eli Lilly has filed six new lawsuits in the United States as part of its effort to combat the...
Insights

Top 10 Strategic Priorities for Pharma CEOs in 2027

Executive Summary The pharmaceutical industry is entering 2027 with a fundamentally different set of strategic challenges than it faced at...
Manufacturing

Aura Biosciences Refocuses on Ocular Oncology Programs and Cuts Workforce by 20%

Aura Biosciences is restructuring its operations under recently appointed Chief Executive Officer Natalie Holles, shifting its focus toward ocular...
Clinical

MoonLake Reports Positive Phase 3 Results for Sonelokimab in Psoriatic Arthritis

MoonLake Immunotherapeutics has reported positive topline results from the...
Commercial

Jazz Pharmaceuticals to Acquire Actio for Up to $1.32 Billion to Add KCNT1 Epilepsy Therapy

Jazz Pharmaceuticals has agreed to acquire Actio Biosciences in...
Insights

Top 10 Technologies Accelerating Drug Discovery

Executive Summary Drug discovery is undergoing one of the most significant technological transformations in pharmaceutical history. Traditional discovery processes have...
Regulatory

FDA Advisory Panel to Review Grail’s Galleri Multi-Cancer Blood Test in September

Grail said the U.S. Food and Drug Administration (FDA) plans to convene a meeting of outside experts on Sept....
Commercial

Actimed Reclaims Rights to Wasting Disease Drug; $126M Faraday Deal Dead

Actimed Therapeutics has regained worldwide rights to its muscle-wasting therapy S-oxprenolol, giving the company full control over the program...
Manufacturing

Ensoma Restructures Operations to Focus on EN-374 for X-Linked Chronic Granulomatous Disease

Boston-based biotechnology company Ensoma has carried out another organizational...
Insights

What an Autonomous Clinical Trial Might Look Like by 2030

Executive Summary Clinical trials are undergoing one of the most...
Regulatory

Takeda’s Orzeyful Approved as First Orexin Agonist for Narcolepsy Type 1

The U.S. Food and Drug Administration (FDA) has approved Takeda’s oveporexton, which will be marketed under the brand name...
Commercial

The biggest pharmaceutical deal ever would be the “unlikely” AstraZeneca-BMS mega-merger

Word spread that two big pharma players, Bristol Myers Squibb and AstraZeneca, each valued at more than $130 billion,...
Commercial

Supernus and Indivior Agree to Create CNS-Focused Company in All-Stock Merger

Supernus Pharmaceuticals and Indivior Pharmaceuticals have agreed to combine in an all-stock merger that will create a central nervous...
Commercial

The biggest pharmaceutical deal ever would be the “unlikely” AstraZeneca-BMS mega-merger

Word spread that two big pharma players, Bristol Myers...
Commercial

Merck KgaA Offers $16M For Two C4 Degraders

Merck KGaA has been brought on board by the...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

Regulatory

Commercial

Eli Lilly Files Six Lawsuits Over Sales of Unapproved Retatrutide

Eli Lilly has filed six new lawsuits in the...
Insights

Top 10 Strategic Priorities for Pharma CEOs in 2027

Executive Summary The pharmaceutical industry is entering 2027 with a...
Manufacturing

Aura Biosciences Refocuses on Ocular Oncology Programs and Cuts Workforce by 20%

Aura Biosciences is restructuring its operations under recently appointed...
Insights

Top 10 Trends Reshaping Pharmaceutical Sales

Executive Summary Pharmaceutical sales are undergoing one of the most...

Research & Development

Market Access

Manufacturing

Lilly Adds $4.5 Billion to Indiana Manufacturing Expansion, Total U.S. Commitments Exceed $50 Billion

Eli Lilly has announced an additional $4.5 billion investment...
Manufacturing

Lilly and Profluent Sign Up to $2.25 Billion Collaboration to Develop AI-Designed Genetic Medicines

Eli Lilly has entered into a multi-program research collaboration...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Reinventing the Pharmaceutical Commercial Model

Executive Summary The pharmaceutical commercial model is entering a period...
Editorial Team -
Manufacturing

Ensoma Restructures Operations to Focus on EN-374 for X-Linked Chronic Granulomatous Disease

Boston-based biotechnology company Ensoma has carried out another organizational...
Editorial Team -
Insights

Top 10 Strategic Priorities for Pharma CEOs in 2027

Executive Summary The pharmaceutical industry is entering 2027 with a...
Editorial Team -